VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
0.200
+0.002 (0.86%)
At close: Mar 9, 2026, 4:00 PM EDT
0.202
+0.003 (1.25%)
After-hours: Mar 9, 2026, 4:22 PM EDT
VolitionRx Employees
VolitionRx had 85 employees as of December 31, 2024. The number of employees decreased by 25 or -22.73% compared to the previous year.
Employees
85
Change (1Y)
-25
Growth (1Y)
-22.73%
Revenue / Employee
$19,627
Profits / Employee
-$305,061
Market Cap
27.12M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Nortech Systems | 744 |
| TELA Bio | 209 |
| Myomo | 185 |
| IRIDEX | 93 |
| Adagio Medical Holdings | 80 |
| Spectral AI | 78 |
| Pulsenmore | 58 |
| Modular Medical | 54 |
VNRX News
- 3 days ago - Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems - PRNewsWire
- 12 days ago - VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution - PRNewsWire
- 27 days ago - Volition Announces the Appointment of New Distributor for Nu.Q® Discover - PRNewsWire
- 27 days ago - VolitionRx Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - PRNewsWire
- 4 weeks ago - Volition Sponsors Symposium at 15th Conference of the European Hidradenitis Suppurativa Foundation - PRNewsWire
- 5 weeks ago - VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q® Cancer Assays - PRNewsWire
- 5 weeks ago - Volition Announces Data to Support Use of Nu.Q® NETs in New Indication - PRNewsWire
- 6 weeks ago - Volition Continues to Extend Access to Nu.Q® Vet Cancer Test - PRNewsWire